Group 1 - The core viewpoint of the article is the launch of the Dongfang Alpha Health Industry Fund, which aims to invest in the health industry and is managed by Meng Yu [1][2][4] - The fund is a mixed equity fund with a management fee of 1.2% of the previous day's net asset value [3][4] - The fund's investment strategy combines top-down and bottom-up approaches, focusing on fundamental analysis to select securities related to the health industry [2][4] Group 2 - As of June 5, 2023, the existing health-themed fund, Dongfang Alpha Medical Health, has seen a net value increase of 26.12% this year, outperforming its benchmark by over 10 percentage points [1][6] - Since Meng Yu's appointment in November 2023, the total return of Dongfang Alpha Medical Health is approximately 6.84%, with a ranking of 172 out of 4553 in its category [6] - The fund's major holdings as of the end of Q1 2025 include companies like Heng Rui Pharmaceutical, Xinda Bio, and Kangfang Bio, with increased exposure to Hong Kong innovative drugs and AI medical investments [6]